Index - 2021
2021 / 2020 / 2019 / 2018
Verklaring afkortingen
- Overig
- Thema-artikelH
- Let op!LO
- Nieuw
Ad26.COV2-S-vaccin
AstraZenica
2021
CanSino
2021
ChAdOx1-S-vaccin
2021
Janssen
2021
Sputnik
2021
Vaxzevria®
2021
Vectorvaccins
2021
covid
2021
covid-19
2021
pandemie
2021
vaccin
2021
Aktiprol®
amisulpride
202121-28
antipsychotica
202121-28
bijwerkingen
202121-28
meta-analyse
202121-28
netwerk meta-analyse
202121-28
amisulpride
Aktiprol®
202121-28
antipsychotica
202121-28
bijwerkingen
202121-28
meta-analyse
202121-28
netwerk meta-analyse
202121-28
angina
CVA
20211-4
LDL-cholesterol
20211-4
TIA
20211-4
beroerte
20211-4
cardiovasculair
20211-4
cerebrovasculair
20211-4
ezetimib
20211-4
hersenbloeding
20211-4
herseninfarct
20211-4
myocardinfarct
20211-4
revascularisatie
20211-4
richtlijnen
20211-4
statinen
20211-4
streefwaarden
20211-4
antipsychotica
Aktiprol®
202121-28
amisulpride
202121-28
bijwerkingen
202121-28
meta-analyse
202121-28
netwerk meta-analyse
202121-28
aritmie
atrium flutter
202117-20
atriumfibrilleren
202117-20
hartritmestoornis
202117-20
medisch hulpmiddel
202117-20
medische app
202117-20
screening
202117-20
AstraZenica
Ad26.COV2-S-vaccin
2021
CanSino
2021
ChAdOx1-S-vaccin
2021
Janssen
2021
Sputnik
2021
Vaxzevria®
2021
Vectorvaccins
2021
covid
2021
covid-19
2021
pandemie
2021
vaccin
2021
atrium flutter
aritmie
202117-20
atriumfibrilleren
202117-20
hartritmestoornis
202117-20
medisch hulpmiddel
202117-20
medische app
202117-20
screening
202117-20
atriumfibrilleren
aritmie
202117-20
atrium flutter
202117-20
hartritmestoornis
202117-20
medisch hulpmiddel
202117-20
medische app
202117-20
screening
202117-20
beroerte
CVA
20211-4
LDL-cholesterol
20211-4
TIA
20211-4
angina
20211-4
cardiovasculair
20211-4
cerebrovasculair
20211-4
ezetimib
20211-4
hersenbloeding
20211-4
herseninfarct
20211-4
myocardinfarct
20211-4
revascularisatie
20211-4
richtlijnen
20211-4
statinen
20211-4
streefwaarden
20211-4
beschermingsduur
COVID-19
202113-16
Comirnaty
202113-16
Moderna
202113-16
SARS-CoV-2
202113-16
doelgroep
202113-16
mRNA
202113-16
messenger-RNA
202113-16
pandemie
202113-16
tozinameran
202113-16
uitwisselbaarheid
202113-16
vaccin
202113-16
virusmutatie
202113-16
bijwerkingen
Aktiprol®
202121-28
amisulpride
202121-28
antipsychotica
202121-28
epidemiologisch onderzoek
20215-7
meta-analyse
202121-28
netwerk meta-analyse
202121-28
post-marketing surveillance
20215-7
registratieonderzoek
20215-7
vaccins
20215-7
vaccinvigilantie
20215-7
CanSino
Ad26.COV2-S-vaccin
2021
AstraZenica
2021
ChAdOx1-S-vaccin
2021
Janssen
2021
Sputnik
2021
Vaxzevria®
2021
Vectorvaccins
2021
covid
2021
covid-19
2021
pandemie
2021
vaccin
2021
cardiovasculair
CVA
20211-4
LDL-cholesterol
20211-4
TIA
20211-4
angina
20211-4
beroerte
20211-4
cerebrovasculair
20211-4
ezetimib
20211-4
hersenbloeding
20211-4
herseninfarct
20211-4
myocardinfarct
20211-4
revascularisatie
20211-4
richtlijnen
20211-4
statinen
20211-4
streefwaarden
20211-4
cerebrovasculair
CVA
20211-4
LDL-cholesterol
20211-4
TIA
20211-4
angina
20211-4
beroerte
20211-4
cardiovasculair
20211-4
ezetimib
20211-4
hersenbloeding
20211-4
herseninfarct
20211-4
myocardinfarct
20211-4
revascularisatie
20211-4
richtlijnen
20211-4
statinen
20211-4
streefwaarden
20211-4
ChAdOx1-S-vaccin
Ad26.COV2-S-vaccin
2021
AstraZenica
2021
CanSino
2021
Janssen
2021
Sputnik
2021
Vaxzevria®
2021
Vectorvaccins
2021
covid
2021
covid-19
2021
pandemie
2021
vaccin
2021
clopidogrel
CYP2C19
20219-12
P2Y12-remmers
20219-12
PCI
20219-12
cytochroom P450
20219-12
genotypering
20219-12
intermediate metabolizer
20219-12
leverenzymen
20219-12
percutane coronaire interventie
20219-12
poor metabolizer
20219-12
prasugrel
20219-12
stentplaatsing
20219-12
stents
20219-12
ticagrelor
20219-12
tromboseprofylaxe
20219-12
Comirnaty
COVID-19
202113-16
Moderna
202113-16
SARS-CoV-2
202113-16
beschermingsduur
202113-16
doelgroep
202113-16
mRNA
202113-16
messenger-RNA
202113-16
pandemie
202113-16
tozinameran
202113-16
uitwisselbaarheid
202113-16
vaccin
202113-16
virusmutatie
202113-16
covid
Ad26.COV2-S-vaccin
2021
AstraZenica
2021
CanSino
2021
ChAdOx1-S-vaccin
2021
Janssen
2021
Sputnik
2021
Vaxzevria®
2021
Vectorvaccins
2021
covid-19
2021
pandemie
2021
vaccin
2021
covid-19
Ad26.COV2-S-vaccin
2021
AstraZenica
2021
CanSino
2021
ChAdOx1-S-vaccin
2021
Janssen
2021
Sputnik
2021
Vaxzevria®
2021
Vectorvaccins
2021
covid
2021
pandemie
2021
vaccin
2021
COVID-19
Comirnaty
202113-16
Moderna
202113-16
SARS-CoV-2
202113-16
beschermingsduur
202113-16
doelgroep
202113-16
mRNA
202113-16
messenger-RNA
202113-16
pandemie
202113-16
tozinameran
202113-16
uitwisselbaarheid
202113-16
vaccin
202113-16
virusmutatie
202113-16
CVA
LDL-cholesterol
20211-4
TIA
20211-4
angina
20211-4
beroerte
20211-4
cardiovasculair
20211-4
cerebrovasculair
20211-4
ezetimib
20211-4
hersenbloeding
20211-4
herseninfarct
20211-4
myocardinfarct
20211-4
revascularisatie
20211-4
richtlijnen
20211-4
statinen
20211-4
streefwaarden
20211-4
CYP2C19
P2Y12-remmers
20219-12
PCI
20219-12
clopidogrel
20219-12
cytochroom P450
20219-12
genotypering
20219-12
intermediate metabolizer
20219-12
leverenzymen
20219-12
percutane coronaire interventie
20219-12
poor metabolizer
20219-12
prasugrel
20219-12
stentplaatsing
20219-12
stents
20219-12
ticagrelor
20219-12
tromboseprofylaxe
20219-12
cytochroom P450
CYP2C19
20219-12
P2Y12-remmers
20219-12
PCI
20219-12
clopidogrel
20219-12
genotypering
20219-12
intermediate metabolizer
20219-12
leverenzymen
20219-12
percutane coronaire interventie
20219-12
poor metabolizer
20219-12
prasugrel
20219-12
stentplaatsing
20219-12
stents
20219-12
ticagrelor
20219-12
tromboseprofylaxe
20219-12
doelgroep
COVID-19
202113-16
Comirnaty
202113-16
Moderna
202113-16
SARS-CoV-2
202113-16
beschermingsduur
202113-16
mRNA
202113-16
messenger-RNA
202113-16
pandemie
202113-16
tozinameran
202113-16
uitwisselbaarheid
202113-16
vaccin
202113-16
virusmutatie
202113-16
epidemiologisch onderzoek
bijwerkingen
20215-7
post-marketing surveillance
20215-7
registratieonderzoek
20215-7
vaccins
20215-7
vaccinvigilantie
20215-7
ezetimib
CVA
20211-4
LDL-cholesterol
20211-4
TIA
20211-4
angina
20211-4
beroerte
20211-4
cardiovasculair
20211-4
cerebrovasculair
20211-4
hersenbloeding
20211-4
herseninfarct
20211-4
myocardinfarct
20211-4
revascularisatie
20211-4
richtlijnen
20211-4
statinen
20211-4
streefwaarden
20211-4
genotypering
CYP2C19
20219-12
P2Y12-remmers
20219-12
PCI
20219-12
clopidogrel
20219-12
cytochroom P450
20219-12
intermediate metabolizer
20219-12
leverenzymen
20219-12
percutane coronaire interventie
20219-12
poor metabolizer
20219-12
prasugrel
20219-12
stentplaatsing
20219-12
stents
20219-12
ticagrelor
20219-12
tromboseprofylaxe
20219-12
hartritmestoornis
aritmie
202117-20
atrium flutter
202117-20
atriumfibrilleren
202117-20
medisch hulpmiddel
202117-20
medische app
202117-20
screening
202117-20
hersenbloeding
CVA
20211-4
LDL-cholesterol
20211-4
TIA
20211-4
angina
20211-4
beroerte
20211-4
cardiovasculair
20211-4
cerebrovasculair
20211-4
ezetimib
20211-4
herseninfarct
20211-4
myocardinfarct
20211-4
revascularisatie
20211-4
richtlijnen
20211-4
statinen
20211-4
streefwaarden
20211-4
herseninfarct
CVA
20211-4
LDL-cholesterol
20211-4
TIA
20211-4
angina
20211-4
beroerte
20211-4
cardiovasculair
20211-4
cerebrovasculair
20211-4
ezetimib
20211-4
hersenbloeding
20211-4
myocardinfarct
20211-4
revascularisatie
20211-4
richtlijnen
20211-4
statinen
20211-4
streefwaarden
20211-4
intermediate metabolizer
CYP2C19
20219-12
P2Y12-remmers
20219-12
PCI
20219-12
clopidogrel
20219-12
cytochroom P450
20219-12
genotypering
20219-12
leverenzymen
20219-12
percutane coronaire interventie
20219-12
poor metabolizer
20219-12
prasugrel
20219-12
stentplaatsing
20219-12
stents
20219-12
ticagrelor
20219-12
tromboseprofylaxe
20219-12
Janssen
Ad26.COV2-S-vaccin
2021
AstraZenica
2021
CanSino
2021
ChAdOx1-S-vaccin
2021
Sputnik
2021
Vaxzevria®
2021
Vectorvaccins
2021
covid
2021
covid-19
2021
pandemie
2021
vaccin
2021
LDL-cholesterol
CVA
20211-4
TIA
20211-4
angina
20211-4
beroerte
20211-4
cardiovasculair
20211-4
cerebrovasculair
20211-4
ezetimib
20211-4
hersenbloeding
20211-4
herseninfarct
20211-4
myocardinfarct
20211-4
revascularisatie
20211-4
richtlijnen
20211-4
statinen
20211-4
streefwaarden
20211-4
leverenzymen
CYP2C19
20219-12
P2Y12-remmers
20219-12
PCI
20219-12
clopidogrel
20219-12
cytochroom P450
20219-12
genotypering
20219-12
intermediate metabolizer
20219-12
percutane coronaire interventie
20219-12
poor metabolizer
20219-12
prasugrel
20219-12
stentplaatsing
20219-12
stents
20219-12
ticagrelor
20219-12
tromboseprofylaxe
20219-12
medisch hulpmiddel
aritmie
202117-20
atrium flutter
202117-20
atriumfibrilleren
202117-20
hartritmestoornis
202117-20
medische app
202117-20
screening
202117-20
medische app
aritmie
202117-20
atrium flutter
202117-20
atriumfibrilleren
202117-20
hartritmestoornis
202117-20
medisch hulpmiddel
202117-20
screening
202117-20
messenger-RNA
COVID-19
202113-16
Comirnaty
202113-16
Moderna
202113-16
SARS-CoV-2
202113-16
beschermingsduur
202113-16
doelgroep
202113-16
mRNA
202113-16
pandemie
202113-16
tozinameran
202113-16
uitwisselbaarheid
202113-16
vaccin
202113-16
virusmutatie
202113-16
meta-analyse
Aktiprol®
202121-28
amisulpride
202121-28
antipsychotica
202121-28
bijwerkingen
202121-28
netwerk meta-analyse
202121-28
Moderna
COVID-19
202113-16
Comirnaty
202113-16
SARS-CoV-2
202113-16
beschermingsduur
202113-16
doelgroep
202113-16
mRNA
202113-16
messenger-RNA
202113-16
pandemie
202113-16
tozinameran
202113-16
uitwisselbaarheid
202113-16
vaccin
202113-16
virusmutatie
202113-16
mRNA
COVID-19
202113-16
Comirnaty
202113-16
Moderna
202113-16
SARS-CoV-2
202113-16
beschermingsduur
202113-16
doelgroep
202113-16
messenger-RNA
202113-16
pandemie
202113-16
tozinameran
202113-16
uitwisselbaarheid
202113-16
vaccin
202113-16
virusmutatie
202113-16
myocardinfarct
CVA
20211-4
LDL-cholesterol
20211-4
TIA
20211-4
angina
20211-4
beroerte
20211-4
cardiovasculair
20211-4
cerebrovasculair
20211-4
ezetimib
20211-4
hersenbloeding
20211-4
herseninfarct
20211-4
revascularisatie
20211-4
richtlijnen
20211-4
statinen
20211-4
streefwaarden
20211-4
netwerk meta-analyse
Aktiprol®
202121-28
amisulpride
202121-28
antipsychotica
202121-28
bijwerkingen
202121-28
meta-analyse
202121-28
P2Y12-remmers
CYP2C19
20219-12
PCI
20219-12
clopidogrel
20219-12
cytochroom P450
20219-12
genotypering
20219-12
intermediate metabolizer
20219-12
leverenzymen
20219-12
percutane coronaire interventie
20219-12
poor metabolizer
20219-12
prasugrel
20219-12
stentplaatsing
20219-12
stents
20219-12
ticagrelor
20219-12
tromboseprofylaxe
20219-12
pandemie
Ad26.COV2-S-vaccin
2021
AstraZenica
2021
COVID-19
202113-16
CanSino
2021
ChAdOx1-S-vaccin
2021
Comirnaty
202113-16
Janssen
2021
Moderna
202113-16
SARS-CoV-2
202113-16
Sputnik
2021
Vaxzevria®
2021
Vectorvaccins
2021
beschermingsduur
202113-16
covid
2021
covid-19
2021
doelgroep
202113-16
mRNA
202113-16
messenger-RNA
202113-16
tozinameran
202113-16
uitwisselbaarheid
202113-16
vaccin
202113-16
vaccin
2021
virusmutatie
202113-16
PCI
CYP2C19
20219-12
P2Y12-remmers
20219-12
clopidogrel
20219-12
cytochroom P450
20219-12
genotypering
20219-12
intermediate metabolizer
20219-12
leverenzymen
20219-12
percutane coronaire interventie
20219-12
poor metabolizer
20219-12
prasugrel
20219-12
stentplaatsing
20219-12
stents
20219-12
ticagrelor
20219-12
tromboseprofylaxe
20219-12
percutane coronaire interventie
CYP2C19
20219-12
P2Y12-remmers
20219-12
PCI
20219-12
clopidogrel
20219-12
cytochroom P450
20219-12
genotypering
20219-12
intermediate metabolizer
20219-12
leverenzymen
20219-12
poor metabolizer
20219-12
prasugrel
20219-12
stentplaatsing
20219-12
stents
20219-12
ticagrelor
20219-12
tromboseprofylaxe
20219-12
poor metabolizer
CYP2C19
20219-12
P2Y12-remmers
20219-12
PCI
20219-12
clopidogrel
20219-12
cytochroom P450
20219-12
genotypering
20219-12
intermediate metabolizer
20219-12
leverenzymen
20219-12
percutane coronaire interventie
20219-12
prasugrel
20219-12
stentplaatsing
20219-12
stents
20219-12
ticagrelor
20219-12
tromboseprofylaxe
20219-12
post-marketing surveillance
bijwerkingen
20215-7
epidemiologisch onderzoek
20215-7
registratieonderzoek
20215-7
vaccins
20215-7
vaccinvigilantie
20215-7
prasugrel
CYP2C19
20219-12
P2Y12-remmers
20219-12
PCI
20219-12
clopidogrel
20219-12
cytochroom P450
20219-12
genotypering
20219-12
intermediate metabolizer
20219-12
leverenzymen
20219-12
percutane coronaire interventie
20219-12
poor metabolizer
20219-12
stentplaatsing
20219-12
stents
20219-12
ticagrelor
20219-12
tromboseprofylaxe
20219-12
registratieonderzoek
bijwerkingen
20215-7
epidemiologisch onderzoek
20215-7
post-marketing surveillance
20215-7
vaccins
20215-7
vaccinvigilantie
20215-7
revascularisatie
CVA
20211-4
LDL-cholesterol
20211-4
TIA
20211-4
angina
20211-4
beroerte
20211-4
cardiovasculair
20211-4
cerebrovasculair
20211-4
ezetimib
20211-4
hersenbloeding
20211-4
herseninfarct
20211-4
myocardinfarct
20211-4
richtlijnen
20211-4
statinen
20211-4
streefwaarden
20211-4
richtlijnen
CVA
20211-4
LDL-cholesterol
20211-4
TIA
20211-4
angina
20211-4
beroerte
20211-4
cardiovasculair
20211-4
cerebrovasculair
20211-4
ezetimib
20211-4
hersenbloeding
20211-4
herseninfarct
20211-4
myocardinfarct
20211-4
revascularisatie
20211-4
statinen
20211-4
streefwaarden
20211-4
SARS-CoV-2
COVID-19
202113-16
Comirnaty
202113-16
Moderna
202113-16
beschermingsduur
202113-16
doelgroep
202113-16
mRNA
202113-16
messenger-RNA
202113-16
pandemie
202113-16
tozinameran
202113-16
uitwisselbaarheid
202113-16
vaccin
202113-16
virusmutatie
202113-16
screening
aritmie
202117-20
atrium flutter
202117-20
atriumfibrilleren
202117-20
hartritmestoornis
202117-20
medisch hulpmiddel
202117-20
medische app
202117-20
Sputnik
Ad26.COV2-S-vaccin
2021
AstraZenica
2021
CanSino
2021
ChAdOx1-S-vaccin
2021
Janssen
2021
Vaxzevria®
2021
Vectorvaccins
2021
covid
2021
covid-19
2021
pandemie
2021
vaccin
2021
statinen
CVA
20211-4
LDL-cholesterol
20211-4
TIA
20211-4
angina
20211-4
beroerte
20211-4
cardiovasculair
20211-4
cerebrovasculair
20211-4
ezetimib
20211-4
hersenbloeding
20211-4
herseninfarct
20211-4
myocardinfarct
20211-4
revascularisatie
20211-4
richtlijnen
20211-4
streefwaarden
20211-4
stentplaatsing
CYP2C19
20219-12
P2Y12-remmers
20219-12
PCI
20219-12
clopidogrel
20219-12
cytochroom P450
20219-12
genotypering
20219-12
intermediate metabolizer
20219-12
leverenzymen
20219-12
percutane coronaire interventie
20219-12
poor metabolizer
20219-12
prasugrel
20219-12
stents
20219-12
ticagrelor
20219-12
tromboseprofylaxe
20219-12
stents
CYP2C19
20219-12
P2Y12-remmers
20219-12
PCI
20219-12
clopidogrel
20219-12
cytochroom P450
20219-12
genotypering
20219-12
intermediate metabolizer
20219-12
leverenzymen
20219-12
percutane coronaire interventie
20219-12
poor metabolizer
20219-12
prasugrel
20219-12
stentplaatsing
20219-12
ticagrelor
20219-12
tromboseprofylaxe
20219-12
streefwaarden
CVA
20211-4
LDL-cholesterol
20211-4
TIA
20211-4
angina
20211-4
beroerte
20211-4
cardiovasculair
20211-4
cerebrovasculair
20211-4
ezetimib
20211-4
hersenbloeding
20211-4
herseninfarct
20211-4
myocardinfarct
20211-4
revascularisatie
20211-4
richtlijnen
20211-4
statinen
20211-4
TIA
CVA
20211-4
LDL-cholesterol
20211-4
angina
20211-4
beroerte
20211-4
cardiovasculair
20211-4
cerebrovasculair
20211-4
ezetimib
20211-4
hersenbloeding
20211-4
herseninfarct
20211-4
myocardinfarct
20211-4
revascularisatie
20211-4
richtlijnen
20211-4
statinen
20211-4
streefwaarden
20211-4
ticagrelor
CYP2C19
20219-12
P2Y12-remmers
20219-12
PCI
20219-12
clopidogrel
20219-12
cytochroom P450
20219-12
genotypering
20219-12
intermediate metabolizer
20219-12
leverenzymen
20219-12
percutane coronaire interventie
20219-12
poor metabolizer
20219-12
prasugrel
20219-12
stentplaatsing
20219-12
stents
20219-12
tromboseprofylaxe
20219-12
tozinameran
COVID-19
202113-16
Comirnaty
202113-16
Moderna
202113-16
SARS-CoV-2
202113-16
beschermingsduur
202113-16
doelgroep
202113-16
mRNA
202113-16
messenger-RNA
202113-16
pandemie
202113-16
uitwisselbaarheid
202113-16
vaccin
202113-16
virusmutatie
202113-16
tromboseprofylaxe
CYP2C19
20219-12
P2Y12-remmers
20219-12
PCI
20219-12
clopidogrel
20219-12
cytochroom P450
20219-12
genotypering
20219-12
intermediate metabolizer
20219-12
leverenzymen
20219-12
percutane coronaire interventie
20219-12
poor metabolizer
20219-12
prasugrel
20219-12
stentplaatsing
20219-12
stents
20219-12
ticagrelor
20219-12
uitwisselbaarheid
COVID-19
202113-16
Comirnaty
202113-16
Moderna
202113-16
SARS-CoV-2
202113-16
beschermingsduur
202113-16
doelgroep
202113-16
mRNA
202113-16
messenger-RNA
202113-16
pandemie
202113-16
tozinameran
202113-16
vaccin
202113-16
virusmutatie
202113-16
vaccin
Ad26.COV2-S-vaccin
2021
AstraZenica
2021
COVID-19
202113-16
CanSino
2021
ChAdOx1-S-vaccin
2021
Comirnaty
202113-16
Janssen
2021
Moderna
202113-16
SARS-CoV-2
202113-16
Sputnik
2021
Vaxzevria®
2021
Vectorvaccins
2021
beschermingsduur
202113-16
covid
2021
covid-19
2021
doelgroep
202113-16
mRNA
202113-16
messenger-RNA
202113-16
pandemie
202113-16
pandemie
2021
tozinameran
202113-16
uitwisselbaarheid
202113-16
virusmutatie
202113-16
vaccins
bijwerkingen
20215-7
epidemiologisch onderzoek
20215-7
post-marketing surveillance
20215-7
registratieonderzoek
20215-7
vaccinvigilantie
20215-7
vaccinvigilantie
bijwerkingen
20215-7
epidemiologisch onderzoek
20215-7
post-marketing surveillance
20215-7
registratieonderzoek
20215-7
vaccins
20215-7
Vaxzevria®
Ad26.COV2-S-vaccin
2021
AstraZenica
2021
CanSino
2021
ChAdOx1-S-vaccin
2021
Janssen
2021
Sputnik
2021
Vectorvaccins
2021
covid
2021
covid-19
2021
pandemie
2021
vaccin
2021
Vectorvaccins
Ad26.COV2-S-vaccin
2021
AstraZenica
2021
CanSino
2021
ChAdOx1-S-vaccin
2021
Janssen
2021
Sputnik
2021
Vaxzevria®
2021
covid
2021
covid-19
2021
pandemie
2021
vaccin
2021
virusmutatie
COVID-19
202113-16
Comirnaty
202113-16
Moderna
202113-16
SARS-CoV-2
202113-16
beschermingsduur
202113-16
doelgroep
202113-16
mRNA
202113-16
messenger-RNA
202113-16
pandemie
202113-16
tozinameran
202113-16
uitwisselbaarheid
202113-16
vaccin
202113-16